About Nono Hu

This author has not yet filled in any details.
So far Nono Hu has created 9 blog entries.

NuMedii, Inc. Announces New Partnership To Discover And Advance New Treatments For Idiopathic Pulmonary Fibrosis

By | 2017-07-26T10:21:03+00:00 April 11th, 2017|

MENLO PARK, Calif., April 11, 2017 – NuMedii, Inc. today announced the formation of a strategic partnership with Three Lakes Partners, LLC, to discover and advance new treatments for idiopathic pulmonary fibrosis (IPF) based on NuMedii’s Big Data intelligence technology. Idiopathic pulmonary fibrosis is a rare chronic progressive and usually fatal interstitial lung disease for [...]

NuMedii, Inc. Wins 2016 Bioprocess International Award For Emerging Company

By | 2017-07-26T10:22:00+00:00 November 2nd, 2016|

PALO ALTO, Calif., November 2, 2016 – NuMedii, Inc. today announced that it is the recipient of the 2016 BioProcess International Emerging Company Award. The event was held in Boston, MA in October 5, 2016 as part of Biotech Week Boston. “We are pleased to be acknowledged for our Company’s contributions to help discover new uses for medicines [...]

NuMedii, Inc. Announces Third Pharmaceutical Discovery Collaboration

By | 2017-08-03T08:01:24+00:00 October 4th, 2016|

PALO ALTO, Calif., October 4, 2016 – NuMedii, Inc. today announced the formation of a discovery collaboration with one of the world’s leading pharmaceutical companies to identify new indications for a number of the undisclosed company’s compounds/candidates. The companies will use NuMedii’s predictive Big Data intelligence technology, which enables the discovery of new uses for [...]

NuMedii Announces New Indications Discovery Collaboration With Astellas

By | 2017-08-03T08:02:28+00:00 January 11th, 2016|

PALO ALTO, Calif., January 11, 2016 – NuMedii, Inc. today announced the formation of a discovery collaboration with Astellas Pharma Inc. (“Astellas”) to identify new indications for a number of undisclosed Astellas compounds using NuMedii’s predictive Big Data intelligence technology. “NuMedii’s predictive Big Data intelligence technology enables the discovery of new uses for both marketed [...]

NuMedii Announces Research Collaboration With Allergan To Explore New Treatments For Psoriasis

By | 2017-07-26T10:24:21+00:00 September 29th, 2015|

PALO ALTO, Calif., September 29, 2015 – NuMedii, Inc. today announced the formation of a research alliance with Allergan to explore new therapeutic options for the potential treatment of psoriasis. The companies will use NuMedii’s predictive Big Data intelligence platform technology, which enables the discovery of new uses for medicines across a number of [...]

NuMedii Supports California Precision Medicine Effort: Collaboration with California Kids Cancer Comparison Project Led by UC Santa Cruz Researchers

By | 2017-07-26T10:24:29+00:00 August 4th, 2015|

Principal Investigators David Haussler, PhD, director, UC Santa Cruz Genomics Institute Theodore Goldstein, PhD, director, MedBook Project Description Each year 500 California children with cancer either lack or fail to respond to standard therapies. Clinical trials currently underway at UC Medical Centers are starting to employ genomic analysis to identify new therapies for these [...]

Thomson Reuters and NuMedii Launch Ground-Breaking Initiative to Identify Drugs for Repurposing

By | 2017-07-26T10:24:37+00:00 November 4th, 2013|

Companies leverage content, Big Data analytics and expertise to improve success of drug discovery PHILADELPHIA, November 4, 2013 – The IP & Science business of Thomson Reuters, the world’s leading provider of intelligent information for businesses and professionals, today announced a strategic initiative with NuMedii, a biotech company dedicated to revolutionizing drug discovery, to [...]

NuMedii Receives $3.5M in a Series A Financing From Claremont Creek Ventures and Lightspeed Venture Partners

By | 2017-07-26T10:24:47+00:00 June 26th, 2013|

Capital Will Be Used To Advance Internal Development Programs for Clinical Testing Company Appoints 3 New Board Members Palo Alto, CA – June 26, 2013 – NuMedii, Inc. today announced that it has recieved $3.5M in a Series A funding led by Claremont Creek Ventures and Lightspeed Venture Partners, with participation by Life Science [...]

NuMedii Announces Strategic Alliance with Aptalis

By | 2017-07-26T10:24:55+00:00 October 3rd, 2012|

Companies will collaborate to discover and develop new methods of treatment for certain gastrointestinal disorders and cystic fibrosis Mountain View, CA – October 03, 2012 –NuMedii, Inc. today announced a strategic alliance with Aptalis Pharma to discover and develop new methods of treatment for certain gastrointestinal disorders and cystic fibrosis. The companies will use [...]